Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Institute Report
Lung Cancer Won't Wait
Building resilience in lung cancer screening and diagnostics based on lessons from the pandemic
Jun 15, 2021
To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

About the Report

The impact of the COVID-19 pandemic on lung cancer screening and diagnostics has been profound, and advances in treatment and development of new technologies have been severely curtailed through this period.  This report looks at how cancer screening and diagnostic services were affected around the world and considers some of the actions that have been taken to tackle the difficulties – and the promise they hold for future efforts. 

Report Summary

The report provides a view to the future and what will be needed to reduce the backlog of patients and to resume services effectively, taking into account the ‘new normal’ and the likelihood that COVID-19 will continue to be present even when the pandemic is over. It considers how we can do this effectively and acknowledges the value of technology and innovations in diagnosis and treatment which are currently being developed, and how they can help to ensure that services are rebuilt more effectively. Awareness campaigns, telemedicine, primary and community care, and collaboration will also be of ongoing critical importance. 

The report also finds that the opportunity to use the impact of the COVID-19 pandemic as a way to accelerate positive change is universally recognised.

Key Findings


Exhibit 1: Oncologists' Caseload Percentage Caseload vs Pre-COVID-19 Phase

The immediate impact of the COVID-19 pandemic on oncology was significant, with many services being suspended or reduced. Oncologists reported a dramatic reduction in caseload numbers immediately, and the effects of this are still being felt almost a year later.  
  • The pressures caused by the COVID-19 pandemic exacerbated the existing diagnostic capacity challenges that lung cancer services face.
  • The introduction of additional infection control measures, including the usage of personal protective equipment, preadmission testing, increased scanner cleaning, and separation of COVID-19 negative and positive patient flows, meant that the time required per diagnostic scan almost doubled (UK). This means that patients are not only presenting late but also take longer to progress through the diagnostic pathway. As referrals are increasing, addressing the considerable backlog of outpatient appointments with half of the pre-COVID diagnostic capacity is likely to lead to considerable bottlenecks within lung cancer services. 
 Exhibit 3: Oncologists Survey Responses Regarding Impacts to Patient Care Due to COVID-19
Increased demand from the pandemic and reduced capacity due to staff shielding and redeployment is putting further strain on an already stretched workforce. Investment in diagnostic capacity will only lead to improvements if there are sufficient levels of staff to carry out the procedures. In addition to this, oncologists report that patients have had new and different needs which have put additional strain on their time. Even as recently as February, this effect was still being felt.
Awareness campaigns, tele-medicine, primary and community care, and collaboration are not only valuable to rebuild services, but to vastly improve them.
Contact Us